TickerFacts.

Ocular Therapeutix, Inc (OCUL): Shareholders' Equity

Annual figures by period end, from SEC filings.

$654.31M
As of 2025-12-31
$520.04M
As of 2026-06-30
+164.5%
3-year compound annual growth
+53.8%
5-year compound annual growth
+22.0%
10-year compound annual growth
2012-12-31: -$46.61M2013-12-31: -$59.47M2014-12-31: $58.70M2015-12-31: $89.59M2016-12-31: $52.01M2017-12-31: $26.15M2018-12-31: $35.88M2019-12-31: -$3.63M2020-12-31: $76.09M2021-12-31: $88.00M2022-12-31: $35.38M2023-12-31: $91.13M2024-12-31: $315.34M2025-12-31: $654.31M$654.31M
2012-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$654.31M+107.5%2026-02-05, Balance as of period end
2024-12-31$315.34M+246.0%2026-02-05, Balance as of period end
2023-12-31$91.13M+157.6%2026-02-05, Balance as of period end
2022-12-31$35.38M-59.8%2025-03-03, Balance as of period end
2021-12-31$88.00M+15.6%2024-03-11, Balance as of period end
2020-12-31$76.09Mn/m2023-03-06, Balance as of period end
2019-12-31-$3.63Mn/m2022-02-28, Balance as of period end
2018-12-31$35.88M+37.2%2020-03-12, Balance as of period end
2017-12-31$26.15M-49.7%2020-03-12, Balance as of period end
2016-12-31$52.01M-41.9%2019-03-07, Balance as of period end
2015-12-31$89.59M+52.6%2018-03-08, Balance as of period end
2014-12-31$58.70Mn/m2017-03-10, Balance as of period end
2013-12-31-$59.47Mn/m2016-03-10, Balance as of period end
2012-12-31-$46.61Mn/a2015-03-20, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Ocular Therapeutix, Inc (OCUL)2025-12-31$654.31M+107.5%
Q32 Bio Inc. (QTTB)2025-12-31$42.01M+640.3%
Agios Pharmaceuticals, Inc. (AGIO)2025-12-31$1.19B-22.6%
Lexicon Pharmaceuticals, Inc. (LXRX)2025-12-31$107.54M-26.3%
Nektar Therapeutics (NKTR)2025-12-31$89.83M+47.9%
Gossamer Bio, Inc. (GOSS)2025-12-31-$122.76Mn/m
Aytu Biopharma, Inc (AYTU)2026-06-30$35.27M+86.0%
Protagonist Therapeutics, Inc (PTGX)2025-12-31$614.71M-9.0%
Septerna, Inc. (SEPN)2025-12-31$381.93M-9.1%

Compare OCUL, QTTB, AGIO, LXRX side by side · Screen every company in Pharmaceutical Preparations ↗